INCY vs NUWE · P/E 14, rev $5.14B vs P/E 0.0, rev $4.4M
Incyte Corporation (INCY) versus Nuwellis Inc (NUWE) — a side-by-side from cached financials, not a winner call.
Incyte Corporation (INCY) is a biotechnology company listed on US.
Nuwellis Inc (NUWE) is a medical devices company listed on US.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. Revenue was up 21.2% from 2024-12-31 to 2025-12-31. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Latest reported NUWE revenue for 2026-06-30 was $4.4M. Net income was -$9.4M. Revenue was up 81.9% from 2026-03-31 to 2026-06-30. NUWE currently screens at market cap $47.8M and trailing P/E 0.0.
INCY currently screens at market cap $20.45B and trailing P/E 14.5. NUWE currently screens at market cap $47.8M and trailing P/E 0.0.
Not investment advice. Open the INCY and NUWE stock pages for the full models.
Not investment advice.